Data supports fast approval for Roche's breast cancer drug: FDA staff
(Reuters) - Trial data on Swiss drugmaker Roche's breast cancer treatment Perjeta supported a faster approval of the drug for use in early stages of t...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/gm7B6Tb8q6U/story01.htm
No comments:
Post a Comment